Novo Nordisk stock falls as weight loss drug fails to beat Eli Lilly

Business

Novo Nordisk Stock Falls As Weight Loss Drug Fails To Beat Eli Lilly

By CNBC

Novo Nordisk stock fell 15% Monday after it said its next-generation weight loss drug didn't meet its key goal of showing that it wasn't inferior to Eli Lilly' s rival drug. The drug, CagriSema, didn't achieve its primary endpoint of demonstrating no ...Read more

Related Posts

Egypt Officially Announces Start of Ramadan 2026 on February 19

Egypt Officially Announces Start of Ramadan 2026 on February 19

Feb 17, 2026
Instagram chief denies social media can be ‘clinically addictive’ in landmark case

Instagram chief denies social media can be ‘clinically addictive’ in landmark case

Feb 11, 2026
Galaxy S25 gets the One UI 8.5 Beta 5 update

Galaxy S25 gets the One UI 8.5 Beta 5 update

Feb 19, 2026
Gun Part Maker Agrees to Pay $1.75 Million in Buffalo Massacre Lawsuits

Gun Part Maker Agrees to Pay $1.75 Million in Buffalo Massacre Lawsuits

Feb 11, 2026
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.